Angiotensin-Converting Enzyme 2 Gene Expression in Breast Tissue.

Area of Science:

• Virology
• Genomics
• Pathology

Background:

• Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) entry into host cells depends on binding to the angiotensin-converting enzyme 2 (ACE2) receptor.
• ACE2 receptors are present in various human tissues, including the lungs, a primary target for SARS-CoV-2.
• Previous research has not confirmed SARS-CoV-2 infection in human breast tissue.

Purpose of the Study:

• To investigate the expression of the ACE2 gene in human breast tissue.
• To compare ACE2 gene expression levels in breast tissue with those in lung tissue.

Main Methods:

• Utilized a public gene expression database.
• Performed a search to identify and analyze ACE2 gene expression data in human breast tissue samples.

Main Results:

• ACE2 gene expression was detected in human breast tissue.
• The expression level of the ACE2 gene was found to be higher in human breast tissue compared to human lung tissue.

Conclusions:

• The elevated ACE2 expression in breast tissue suggests it could be a potential target for SARS-CoV-2.
• This finding implies that SARS-CoV-2 infection may lead to pathology in breast tissue.
• Further research is warranted to understand the implications of ACE2 expression in breast tissue concerning COVID-19.